Phase 2 Initial Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2Phase 3
Effect of Interferon Gamma as a Treatment for Post-aggressive Immunosuppression in Intensive Care Units, a Randomized Bayesian Double-blind Controlled Trial Versus Placebo
Post-aggressive ImmunosuppressionAdult Patients Admitted to Intensive Care With Initial Severity (SOFA of the First 24 Hours Post-admission ≥ 6Adult Under Mechanical Ventilation, and Presenting an mHLA-DR Less Than 8,000AB/C
Assistance Publique - Hôpitaux de Paris170 enrolled2 locationsNCT06694740
Recruiting
Phase 2
Orelabrutinib Combined With Zuberitamab in the Initial Treatment of MZL
Initial MZLUntreated MZLBTKi+1 more
Li Zhiming33 enrolled2 locationsNCT06985472
Recruiting
Phase 2
Combination of Gemcitabine, Albumin-paclitaxel , Sintilimab and Bevacizumab in Unresectable Gallbladder Cancer
Gallbladder CancerInitially Unresectablethe First Line Treatment
Lu Wang, MD, PhD50 enrolled1 locationNCT05757336
Completed
Phase 2
The effect of the antiviral drug, Peg-interferon, in patients with relapsed haematological malignancy after initial sibling or volunteer unrelated allogeneic haematopoietic progenitor cell transplantation (HPCT)
Haematological relapse (more than or equal to 5 percent blasts) or non-Haematological relapse (molecular, cytogenetic or flow cytometry only) after initial sibling or volunteer unrelated allogeneic HPCT.
Royal Brisbane and Womens Hospital30 enrolled1 locationACTRN12612000728831